| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014528A1 Method of preparing immune response-inducing dendritic cells |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001014408A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 03/01/2001 | WO2001014405A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | WO2001014401A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 03/01/2001 | WO2001014387A1 28-epirapalogs |
| 03/01/2001 | WO2001014375A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 03/01/2001 | WO2001014347A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 03/01/2001 | WO2001014342A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013946A2 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 03/01/2001 | WO2001013943A2 Stress protein-peptide complexes as vaccines against intra cellular pathogens |
| 03/01/2001 | WO2001013942A2 Trehalose producing prokaryotic cells as vaccines |
| 03/01/2001 | WO2001013925A1 Remedies |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073415A3 A method for the transfer of antigens to dendritic cells |
| 03/01/2001 | WO2000068223A8 Ureas and their use as cell adhesion modulators |
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
| 03/01/2001 | WO2000056361A3 Vaccine composition |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO2000023037A8 Two chamber cartridge for atomizers |
| 03/01/2001 | WO1998042379A3 Chemically and thermally stable norastemizole formulations |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
| 03/01/2001 | DE19941115A1 Neue Benzoxazin- und Bezothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and Bezothiazin derivatives and their use in medicaments |
| 03/01/2001 | DE19940740A1 Pharmazeutische Salze Pharmaceutical Salts |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE19939982A1 Verfahren zur Isolierung und Aufreinigung von Gräserpollenallergenen A process for the isolation and purification of grass pollen allergens |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383559A1 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383451A1 28-epirapalogs |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382467A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2382174A1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381340A1 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 02/28/2001 | EP1078633A2 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 02/28/2001 | EP1078629A2 Use of Salmeterol and salts for the treatment of inflammation and allergy |
| 02/28/2001 | EP1078093A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/28/2001 | EP1078092A2 Expression vectors for stimulating an immune response and methods of using the same |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
| 02/28/2001 | EP1078007A2 Verotoxin b subunit for immunization |
| 02/28/2001 | EP1078001A2 Il-6 antagonist peptides |
| 02/28/2001 | EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/28/2001 | EP1077947A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077940A1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 02/28/2001 | EP1077937A1 METHOD OF LOCKING 1$g(a)-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077930A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077723A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 02/28/2001 | EP1077722A2 Methods and products for inducing mucosal immunity |
| 02/28/2001 | EP1077721A1 Prevention and treatment of hypergastrinemia |
| 02/28/2001 | EP1077720A2 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 02/28/2001 | EP1077719A1 Vaccine delivery system |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077713A1 Stable oil-in-glycerin emulsion |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | EP1077687A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP1077676A2 Cyclosporin preparations |
| 02/28/2001 | EP0769902A4 Methods for reducing hyperacute rejection of xenografts |
| 02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
| 02/28/2001 | CN1285828A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CN1285754A Monoclonal human matural antibodies |
| 02/28/2001 | CN1285753A Transdermal delivery of particulate vaccine compositions |
| 02/28/2001 | CN1285752A Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 02/28/2001 | CN1285750A New composition of matter |
| 02/28/2001 | CN1285747A Combination therapy for treating AIDS |
| 02/28/2001 | CN1285194A Crustaceous extract health care foods and preparation method thereof |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |